Buys C H, Dejong A S, Bouma J M, Gruber M
Biochim Biophys Acta. 1975 May 5;392(1):95-100. doi: 10.1016/0304-4165(75)90169-5.
The clearance from the blood and the conformation of serum albumin modified by nitroguanidination and labeled with 125-I have been studied. Like formaldehyde-denatured albumin, but in contrast to native albumin, the nitroguanidinated derivative is rapidly cleared from the blood and taken up in lysosomes of liver sinusoidal cells. Although 94% of the free amino groups were blocked by nitroguanidination, we could not detect significant conformational changes using gel filtration, determination of reducible disulfide groups, and titration of tyrosine residues. It is concluded that extensive denaturation is no prerequisite for the uptake of albumin derivatives in liver sinusoidal cells. It is suggested that the nitroguanidinated protein, in contrast to native albumin, is bound on membrane receptors of sinusoidal cells. The nitroguanidino groups themselves might be bound on these receptors, but it seems equally possible that the blocking of positive charges of the albumin molecule or minor, local conformational changes of the protein are sufficient for the binding on the receptors.
研究了经硝基胍修饰并用125-I标记的血清白蛋白从血液中的清除情况及其构象。与甲醛变性白蛋白一样,但与天然白蛋白不同,硝基胍化衍生物能迅速从血液中清除,并被肝窦状细胞的溶酶体摄取。尽管94%的游离氨基被硝基胍化阻断,但我们通过凝胶过滤、可还原二硫键的测定以及酪氨酸残基的滴定,未检测到明显的构象变化。结论是,肝窦状细胞摄取白蛋白衍生物并不需要广泛变性。有人提出,与天然白蛋白不同,硝基胍化蛋白与窦状细胞的膜受体结合。硝基胍基团本身可能与这些受体结合,但白蛋白分子正电荷的阻断或蛋白质微小的局部构象变化似乎同样足以使其与受体结合。